Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins

Neurotoxicology. 2010 Aug;31(4):399-402. doi: 10.1016/j.neuro.2010.04.002. Epub 2010 May 11.

Abstract

We present four cases of fragile X premutation carriers with early neurological symptoms, including symptoms consistent with multiple sclerosis (MS) and fragile X-associated tremor/ataxia syndrome (FXTAS). Each patient had significant exposure to one or more environmental neurotoxicants that have documented neurotoxicity (i.e. hexachlorocyclopentadiene or C56, Agent Orange, and 2,4- or 2,6-toluene diisocyanate and dichlormate). We hypothesize that premutation carriers are a vulnerable group to neurotoxins because elevated mRNA in the premutation can lead to early cell death and brain disease, leading to neuropsychiatric and neurological symptoms consistent with FXTAS.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Female
  • Fragile X Mental Retardation Protein / genetics*
  • Fragile X Syndrome / complications
  • Fragile X Syndrome / diagnosis
  • Fragile X Syndrome / genetics
  • Heterozygote*
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / genetics
  • Neurotoxicity Syndromes / complications
  • Neurotoxicity Syndromes / diagnosis
  • Neurotoxicity Syndromes / genetics*
  • Neurotoxins / toxicity*

Substances

  • FMR1 protein, human
  • Neurotoxins
  • Fragile X Mental Retardation Protein